IMU

0.00%

5.9¢ imugene limited

Yes, unless you happen to invest in CSL which is the biotech...

First 15273 Last

Share
Profile

Follow
AlCp

26,627 Posts.

1727

18/08/23

17:03

Post #: 69424276
Share

Originally posted by y0w4ll3t ↑

Just some observations. I've been watching IMU for a long time now and took my first nibble in today. I've found over the years that biotechs almost universally need to be traded. What I mean by this is that your chances of finding the one that happens to make it are slim. What's worse, is that often the goal is a BP buyout which from a traders perspective is more like a sword of Damocles. Why? Because it limits your upside. Say you value their opportunity at some percentage of TAM, realistically will that full value actually be realised? Likely not because your time frame is limited by when the buyout will occur. Which means timing is critical on biotechs. You need to enter when they have decent cash balances, are progressed and enter with a parcel small enough that you are prepared to defend. Where by defend I mean you have to be prepared on the fund raises and set backs to average down so that your average price is lower than the premiums that are being paid above current price for TO in the sector. Otherwise you can be right and still lose money. In times such as now where CRs have to be done at larger discounts and TO are at smaller premiums I feel like it is a tricky sector to be in and not as simple as other sectors where you value it, buy in and can hold for the long run and win if your thesis is correct. If you are taking care of your average then the upside of course is much larger. I hope that perspective helps someone.

Expand

Yes, unless you happen to invest in CSL which is the biotech stock everyone is now trying to find.......

IMU Price at posting: 7.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

STX

Strike Energy secures $153 million for Perth Basin gas projects

EMD

Emyria's Empax Centre chosen for mental health clinical trial

FHE

Frontier Energy achieves key milestone for Waroona energy project

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

BRX

Belararox delineates another porphyry in Argentina at Tambo South

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

There are more pages in this discussion • 9,648 more messages in this thread...

First 15273 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change 0.000(0.00%)		Mkt cap ! $431.8M

Open	High	Low	Value	Volume
5.9¢	5.9¢	5.6¢	$1.037M	17.94M

Buyers (Bids)

No.	Vol.	Price($)
8	1882949	5.8¢

Sellers (Offers)

Price($)	Vol.	No.
5.9¢	399643	3

View Market Depth

No.	Vol.	Price($)
7	1874329	0.058
9	1728227	0.057
23	4466894	0.056
27	3648665	0.055
8	305000	0.054

Price($)	Vol.	No.
0.059	1360	1
0.060	2622845	17
0.061	773907	4
0.062	2227969	6
0.063	243179	3

Last trade - 16.10pm 21/06/2024 (20 minute delay)

IMU (ASX) Chart

Yes, unless you happen to invest in CSL which is the biotech...

Strike Energy secures $153 million for Perth Basin gas projects

Emyria's Empax Centre chosen for mental health clinical trial

Frontier Energy achieves key milestone for Waroona energy project

Cultural heritage agreement puts Walford Creek exploration back on the map

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Belararox delineates another porphyry in Argentina at Tambo South

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes, unless you happen to invest in CSL which is the biotech...

Top Stories

Strike Energy secures $153 million for Perth Basin gas projects

Emyria's Empax Centre chosen for mental health clinical trial

Frontier Energy achieves key milestone for Waroona energy project

Cultural heritage agreement puts Walford Creek exploration back on the map

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Belararox delineates another porphyry in Argentina at Tambo South

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News